Thrasher, J., Polsky, S., Hovsepian, L., Nowotny, I., Pierre, S., Bois De Fer, B., . . . Garg, S. K. (2020). Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults with Type 1 Diabetes: A Randomized, Open-Label Clinical Trial. Diabetes Technol Ther.

Thrasher, James, Sarit Polsky, Lionel Hovsepian, Irene Nowotny, Suzanne Pierre, Béatrice Bois De Fer, Anuj Bhargava, Bhaswati Mukherjee, und Satish K. Garg. "Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults With Type 1 Diabetes: A Randomized, Open-Label Clinical Trial." Diabetes Technol Ther 2020.

Thrasher, James, et al. "Safety and Tolerability of Insulin Aspart Biosimilar SAR341402 Versus Originator Insulin Aspart (NovoLog) When Used in Insulin Pumps in Adults With Type 1 Diabetes: A Randomized, Open-Label Clinical Trial." Diabetes Technol Ther 2020.